Patient preferences for colon cancer screening

Screening for colon cancer

Colorectal cancer screening reduces mortality in individuals 50 years and older. Each of the screening tests currently available has advantages and limitations, and there is no consensus as to which test or combination of tests is best. What is clear, however, is that the rates of colorectal cancer screening remain low. This review summarizes the clinical evidence supporting colorectal cancer s...

Colon cancer screening.

Colorectal cancer (CRC) is a common clinical problem which is increasing in Jamaica. It is the second highest cause of cancer mortality in most developed countries (1). In Jamaica, CRC is the third commonest cancer in both males and females (2). Colorectal cancer is preventable. The majority of such cancers arise from benign adenomatous polyps and in most cases it takes about ten years for a sm...

Colon cancer screening

Colorectal cancer is a major health problem worldwide. Last year in the United States alone, more than 130 000 people were diagnosed with colorectal cancer and more than 56 000 died of their disease. Fortunately, this neoplasm is highly suited to screening because of its long preclinical phase, during which it is detectable and curable. Nevertheless, screening programs for colorectal cancer hav...

Screening For Colon and Rectal Cancer.

U.S. practices for colon cancer screening.

As the prevalence of gastric carcinoma decreases in Japan, the prevalence of colon cancer has been increasing. Examination of the screening practices for colon cancer in the United States can offer insight into practices that may be useful in Japan. This paper will review the epidemiology and risk factors for colon cancer, the genetics of colon cancer, prevention issues, screening modalities, a...